Precision Molecular Pathology of Breast Cancer

This volume provides a comprehensive review of the molecular mechanisms involved in precancerous lesions and benign and malignant breast tumors. Given the complex molecular pathways in breast cancer biology, the book simplifies these complex mechanisms and highlights the practical issues important for daily practice. Sections are structured to review breast carcinogenesis and the role of familial predisposition and stem cells in initiation and progression of breast cancer. In-depth chapters present morphologic and molecular correlations in precancerous and malignant breast lesions, while outlining highly practical issues that are in practice today in breast pathology, such as evaluation of estrogen, progesterone receptors, and HER-2.
Written by experts in the field, Precision Molecular Pathology of Breast Cancer is a valuable resource that covers the current practice of breast pathology and looks into the future with an emphasis on the molecular basis of breast cancer.


Ashraf Khan, MD, FRCPath
University of Massachusetts Medical School, Department of Pathology, Worcester, MA, USA
Ian O. Ellis, MD, FRCPath
University of Nottingham, Department of Histopathology, Nottingham City Hospital, Nottingham, UK
Andrew M. Hanby, BM, FRCPath
St. James University Hospital/University of Leeds, Leeds Institute of Cancer and Pathology, Leeds, West Yorkshire, UK
Ediz F. Cosar, MD
UMassMemorial Medical Center, University of Massachusetts Medical School, Department of Pathology, Worcester, MA, USA
Emad Rakha, MD, PhD, FRCPath
University of Nottingham, Department of Histopathology, Nottingham City Hospital, Nottingham, UK
Dina Kandil, MD
UMassMemorial Medical Center, University of Massachusetts Medical School, Department of Pathology, Worcester, MA, USA